Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
LOW RISK
Score updated Aug 28, 2026

AVXL — Anavex Life Sciences Corp. Dilution Risk Tracker

Track AVXL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AVXL — Get alerts when the score changes →

As of August 28, 2026, Anavex Life Sciences Corp. (AVXL) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Anavex Life Sciences Corp. has a market capitalization of $280.80M, 92.67M shares outstanding, 194 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 10.8% potential dilution
🔔 Track AVXL — Get forecast alerts →

Market Data

Market Cap$280.80M
Shares Outstanding92.67M
Float89.78M
Cash$131.75M
Debt$345
Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)
194 institutional holders · 49.69M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 7.73M shares
#2 BlackRock, Inc. 7.61M shares
#3 STATE STREET CORP 4.51M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest14.43M
Days to Cover14.4
% of Float16.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-09-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual AVXL Dilution Snapshot

Anavex Life Sciences Corp. (AVXL) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track AVXL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AVXL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AVXL
AVXL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.